In the face of the COVID-19 pandemic, cancer surgeons worldwide have devised models to aid with the prioritization of canceled (backlog) elective and upcoming cancer surgeries.
In the face of the COVID-19 pandemic, cancer surgeons worldwide have devised models to aid with the prioritization of canceled (backlog) elective and upcoming cancer surgeries. Researchers have also strongly advised conducting COVID-19 testing at various time points before and after any surgical procedures with the aim of minimizing the risk of developing COVID-19–related mortality peri- and postoperatively, particularly in high-risk patients undergoing major surgeries.
During the 2020 European Society of Surgical Oncology (ESSO)’s annual meeting, speaker and scientist, Roberto Valente, MD, Ph.D., who was involved in modifying the SWALIS prioritization model, shared their findings from implementing it in Spring 2020 to prioritize elective surgery throughout and beyond the COVID-19 pandemic in Italy. SWALIS 2020 dynamically reorders the surgical waiting list for cancer patients from least to most urgent in real-time, thereby ensuring priority-based surgical access and scheduling for past, present, and incoming patients.
Following the SWALIS 2020 feasibility phase (n=55 patients), researchers were able to successfully prioritize 240 referrals using this model without any major issues 222 cancer patients underwent surgery without related complications or delayed discharges.
You can read more about how SWALIS 2020 allowed safe surgical procedures here.
Author Lakshmi Yeturu is an intern with the Colon Cancer Foundation.
CRC POP: Arming Newly Diagnosed CRC Patients With Useful Resources
March 3rd 2021Brian Dooreck, MD, of the Gastrointestinal Diagnostic Centers, Pembroke Pines, Florida, spoke with the Colon Cancer Foundation about their newly launched Colorectal Cancer Provider Outreach Program (CRC POP)—it’s evolution and mission.
Read More
Discussing The New USPSTF Colon Cancer Screening Guidelines
November 1st 2020The anticipated draft recommendation from the U.S. Preventive Task Force Services (USPSTF) is here…and it brought forth great news for the colorectal cancer (CRC) community. This independent panel of experts has proposed lowering CRC screening age for average-risk adults from 50 to 45 years.
Read More
Skipped Cancer Screenings: Racial Inequality, Coronavirus, or Denial?
October 27th 2020As the nation moves towards a new era of inclusivity and diversity, the American Society of Clinical Oncology (ASCO)’s fourth annual survey sheds light on racial inequality and other issues that influence cancer screening and health care access amidst the COVID-19 pandemic.
Read More